HSS and pSivida report positive phase 1 knee osteoarthritis pain study data
pSivida announced the results of a Phase I safety and exploratory efficacy pilot study for a sustained release implant integrating pSivida's Durasert™ delivery technology and an HSS-designed implantable device. Based on the study findings, the implant was well tolerated. December 14, 2017